Extensively Drug-Resistant Tuberculosis: Clinical Trials

1 trial for Extensively Drug-Resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Extensively Drug-Resistant Tuberculosis: new trials by email Literature Review of Extensively Drug-Resistant Tuberculosis trials Research Report on Extensively Drug-Resistant Tuberculosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients
Addition of different doses of clarithromycin. - Multidrug-resistant Tuberculosis, Extensively Drug-resistant Tuberculosis
Phase 4CompletedUniversity Medical Center Groningen72011-12-012013-07-01

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Mycobacterium Infections (1)  ·  Tuberculosis (1)

Interventions

Clarithromycin (1)

Sponsors

University Medical Center Groningen (1)

Countries

Netherlands (1)

Top investigators

Jan-Willem C Alffenaar, PhD, PharmD (1)

Results publications

PMID 23520311